Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types

In the clinical trials of the quadrivalent human papillomavirus (qHPV) vaccine, antibodies were measured by a competitive Luminex immunoassay (HPV-4 cLIA). A nine-valent HPV (9vHPV) vaccine targeting the types in the qHPV vaccine (HPV6/11/16/18), as well as 5 of the next most frequent HPV types foun...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Vaccin Immunother
Asıl Yazarlar: Roberts, Christine, Green, Tina, Hess, Erica, Matys, Katie, Brown, Martha J, Haupt, Richard M, Luxembourg, Alain, Vuocolo, Scott, Saah, Alfred, Antonello, Joseph
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2014
Konular:
Short Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896759/
https://ncbi.nlm.nih.gov/pubmed/25424920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29205
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller